Results 221 to 230 of about 3,449,271 (349)

Soft Nanocarriers as Antimicrobial Co‐Delivery Systems to Combat Resistant Infections

open access: yesAdvanced Healthcare Materials, EarlyView.
Soft nanocarrier‐based co‐delivery systems present a versatile and promising platform for combating antimicrobial resistance (AMR) by enabling spatiotemporally controlled, pathogen‐specific drug release. Their tunable physicochemical properties allow for the co‐encapsulation of synergistic antimicrobial agents, optimization of drug ratios, and surface ...
Anamarija Nikoletic   +5 more
wiley   +1 more source

Evaluation of Aqueous and Ethanolic Extracts for the Green Synthesis of Zinc Oxide Nanoparticles from <i>Tradescantia spathacea</i>. [PDF]

open access: yesNanomaterials (Basel)
Trejo-Flores PG   +9 more
europepmc   +1 more source

Gasotransmitters in Modern Medicine: Promises and Challenges in the Use of Porous Crystalline Carriers

open access: yesAdvanced Healthcare Materials, EarlyView.
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto   +2 more
wiley   +1 more source

Reaction of Propylene Oxide and Zinc Alkoxide

open access: bronze, 1966
Teiji Tsuruta   +2 more
openalex   +2 more sources

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

open access: yesAdvanced Healthcare Materials, EarlyView.
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy